Pulmonary Artery Catheters May Improve Heart Failure Quality Of Life
This article was originally published in The Gray Sheet
Executive Summary
Pulmonary artery catheterization (PAC) of severe heart failure patients is not associated with lower mortality, although it may assist doctors in improving patient quality of life, according to ESCAPE trial findings
You may also be interested in...
Pulmonary catheter study proposals to be reviewed by NHLBI advisory board Sept. 4.
PULMONARY ARTERY CATHETER RESEARCH PROPOSALS TO BE REVIEWED BY NHLBI advisory board on Sept. 4. The National Heart, Lung and Blood Institute's advisory panel is slated to review research proposals developed at an Aug. 25-26 workshop in Alexandria, Virginia sponsored by FDA and the National Institutes of Health to address questions about the safety and effectiveness of pulmonary artery catheters.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.